These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33887726)

  • 61. A review on age-related cancer risks in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Schuurs-Hoeijmakers JHM; Vos JR
    Clin Genet; 2021 Feb; 99(2):219-225. PubMed ID: 33140411
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.
    Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF
    Fam Cancer; 2014 Mar; 13(1):57-63. PubMed ID: 23934601
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.
    Comeau D; Allain V; Maillet-Lebel N; Ben Amor M
    Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Imaging of PTEN-related abnormalities in the central nervous system.
    Dhamija R; Hoxworth JM
    Clin Imaging; 2020 Apr; 60(2):180-185. PubMed ID: 31927175
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndrome.
    MacFarland SP; Duvall M; Kemajou RT; Baldino SE; Zelley K; Black C; Thomas A; Thomas NH; Ruffner M; Li Y; Miller JS; Brodeur GM; Shabason E
    Am J Med Genet A; 2024 Aug; 194(8):e63608. PubMed ID: 38546160
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phosphatase and Tensin Homolog Hamartoma Tumor Syndrome: A Case Report.
    Holt AE; Ferguson BL; Gibson TM; Satheesh KM; Cobb CM
    Clin Adv Periodontics; 2016 Feb; 6(1):21-26. PubMed ID: 32689721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thyroid involvement in two patients with Bannayan-Riley-Ruvalcaba syndrome.
    Peiretti V; Mussa A; Feyles F; Tuli G; Santanera A; Molinatto C; Ferrero GB; Corrias A
    J Clin Res Pediatr Endocrinol; 2013; 5(4):261-5. PubMed ID: 24379037
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PTEN hamartoma tumor syndrome.
    Mester J; Charis E
    Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exploring the neurological features of individuals with germline PTEN variants: A multicenter study.
    Dhawan A; Baitamouni S; Liu D; Busch R; Klaas P; Frazier TW; Srivastava S; Parikh S; Hsich GE; Friedman NR; Ritter DM; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C
    Ann Clin Transl Neurol; 2024 May; 11(5):1301-1309. PubMed ID: 38501559
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proteus-Like Syndrome: A Rare Phenotype of Phosphatase and Tensin Homolog Hamartoma Tumor Syndrome.
    Abu-Shaban K; Bakri K; Kihm A; Elsamaloty M; Elsamaloty H
    Cureus; 2022 Apr; 14(4):e24135. PubMed ID: 35582557
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Formation of a de novo intracranial arteriovenous fistula in a child with PTEN hamartoma tumor syndrome.
    Roth SG; Feldman MJ; Borst AJ; Froehler MT
    Childs Nerv Syst; 2022 May; 38(5):1029-1033. PubMed ID: 34409504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.
    Löffler MW; Steinhilber J; Hilke FJ; Haen SP; Bösmüller H; Montes-Mojarro IA; Bonzheim I; Stäbler A; Faust U; Grasshoff U; Königsrainer I; Rammensee HG; Kanz L; Königsrainer A; Beckert S; Riess O; Schroeder C
    BMC Med Genet; 2018 Aug; 19(1):144. PubMed ID: 30111295
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SHH medulloblastoma and very early onset of bowel polyps in a child with
    Caroleo AM; Rotulo S; Agolini E; Macchiaiolo M; Boccuto L; Antonelli M; Colafati GS; Cacchione A; Megaro G; Carai A; De Ioris MA; Lodi M; Tornesello A; Simone V; Torroni F; Cinalli G; Mastronuzzi A
    Front Mol Neurosci; 2023; 16():1228389. PubMed ID: 37692099
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
    Morgan FC; Yehia L; McDonald C; Martinez-Agosto JA; Hardan AY; Tamburro J; Sahin M; Bayart C; Eng C;
    J Am Acad Dermatol; 2023 Jul; 89(1):90-98. PubMed ID: 35143913
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.
    Barletta JA; Bellizzi AM; Hornick JL
    Am J Surg Pathol; 2011 Oct; 35(10):1505-11. PubMed ID: 21921783
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
    Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thyroid pathology, a clue to PTEN hamartoma tumor syndrome.
    Lee Y; Oh YL
    J Pathol Transl Med; 2023 May; 57(3):178-183. PubMed ID: 36977604
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
    Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
    J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Looking for the hidden mutation: Bannayan-Riley-Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A.
    Golas MM; Auber B; Ripperger T; Pabst B; Schmidt G; Morlot M; Diebold U; Steinemann D; Schlegelberger B; Morlot S
    Am J Med Genet A; 2019 Jul; 179(7):1383-1389. PubMed ID: 31062505
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and molecular aspects of PTEN mutations in 10 pediatric patients.
    Isik E; Simsir OS; Solmaz AE; Onay H; Atik T; Aykut A; Durmaz A; Cogulu O; Ozkinay F
    Ann Hum Genet; 2020 Jul; 84(4):324-330. PubMed ID: 32162695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.